Guse Kyle 4
4 · PLUS THERAPEUTICS, INC. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Guse Kyle
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-08-13+40,000→ 40,000 totalExercise: $0.57Exp: 2035-08-12→ Common Stock (40,000 underlying) - Award
Stock Option (Right to Buy)
2025-08-13+297,794→ 297,794 totalExercise: $0.57Exp: 2035-08-12→ Common Stock (297,794 underlying)
Footnotes (2)
- [F1]The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.
- [F2]The options vest monthly over 24 months from the Grant Date in substantially equal monthly installments.